1998
DOI: 10.1016/s0002-9149(98)00361-0
|View full text |Cite
|
Sign up to set email alerts
|

Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
40
0

Year Published

2000
2000
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(40 citation statements)
references
References 13 publications
0
40
0
Order By: Relevance
“…Our search strategy included any patient admitted with a primary discharge diagnosis for heart failure (ICD 9-CM code 428 or diagnosis-related group code 127). 28,29 ADHF at presentation was confirmed through chart review using the Framingham criteria (sensitivity, 100%; specificity, 78%; see Table 1). 30 Only the patients who met the Framingham criteria were included in the study population.…”
Section: Patient Populationmentioning
confidence: 99%
“…Our search strategy included any patient admitted with a primary discharge diagnosis for heart failure (ICD 9-CM code 428 or diagnosis-related group code 127). 28,29 ADHF at presentation was confirmed through chart review using the Framingham criteria (sensitivity, 100%; specificity, 78%; see Table 1). 30 Only the patients who met the Framingham criteria were included in the study population.…”
Section: Patient Populationmentioning
confidence: 99%
“…ACE inhibitor dosages were converted to enalapril-equivalent dosages according to the target daily doses recommended for heart failure in the Dutch reference desk book. This method has been used previously [19] and uses enalapril 20 mg as reference dose with equivalent doses of captopril 150 mg, ramipril 10 mg, quinapril 20 mg, lisinopril 20 mg, fosinopril 40 mg and perindopril 4 mg.…”
Section: Outcome Variablesmentioning
confidence: 99%
“…Rehospitalization is increasingly being used not only as a clinical outcome, but also as an end point in clinical trials of 15 have been shown to decrease hospitalization rates in patients with congestive heart failure, and ␤-blockers have been shown to decrease the need for rehospitalization in survivors of an acute coronary syndrome. 16 In the field of stroke, antiplatelet therapy before hospital discharge is a widely accepted recommendation for secondary stroke prevention as well as an indicator of quality of stroke care.…”
Section: Rehospitalization: a New End Point In Clinical Trials?mentioning
confidence: 99%